" clear="all" />
' target="_blank" rel="external">" align="left" />
[1]Ramazanoglu M, Lutz R, Rusche P, et al. Bone response to biomimetic implants delivering BMP-2 and VEGF: an immunohistochemical study[J]. J Craniomaxillofac Surg, 2013, 41(8): 826. [2]Tsuji K, Bandyopadhyay A, Harfe B D, et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing[J]. Nat Genet, 2006, 38(12): 1424 [3]Lauzon M A, Bergeron E, Marcos B, et al. Bone repair: new developments in growth factor delivery systems and their mathematical modeling[J]. J Control Release, 2012, 162(3): 502 [4]No?l D, Gazit D, Bouquet C, et al. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells[J]. Stem Cells, 2004, 22(1): 74 [5]Mizuguchi H, Hayakawa T. Characteristics of adenovirus-mediated tetracycline-controllable expression system[J]. Biochim Biophys Acta, 2001, 1568(1): 21 [6]Qian Dongyang, Bai Bo, Yan G, et al. Construction of doxycycline-mediated BMP-2 transgene combining with APA microcapsules for bone repair[J]. Artif Cells Nanomed Biotechnol, 2016, 44(1): 270 [7]Lee H H, O’malley M J, Friel N A, et al. Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair[J]. Osteoarthritis Cartilage, 2013, 21(2): 385 [8]Wang Y H, Ho M L, Chang J K, et al. Microporation is a valuable transfection method for gene expression in human adipose tissue-derived stem cells[J]. Mol Ther, 2009, 17(2): 302 [9]Kempen D H, Lu L C, Heijink A, et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration[J]. Biomaterials, 2009, 30(14): 2816 [10]Gurkan U A, Gargac J, Akkus O. The sequential production profiles of growth factors and their relations to bone volume in ossifying bone marrow explants[J]. Tissue Eng Part A, 2010, 16(7): 2295 [11]Wübbenhorst D, Biol D, DumLer K, et al. Tet-regulated BMP-2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defects[J]. Arthritis Rheum, 2010, 62(7):2037 [12]Jazwa A, Florczyk U, Jozkowicz A, et al. Gene therapy on demand: site specific regulation of gene therapy[J]. Gene, 2013, 525(2): 229 [13]Shiota G, Yoshida Y. "Tet-On" system toward hepatic differentiation of human mesenchymal stem cells by hepatocyte nuclear factor[J]. Methods Mol Biol, 2012, 826: 125 [14]Stieger K, Belbellaa B, Le Guiner C, et al. In vivo gene regulation using tetracycline-regulatable systems[J]. Adv Drug Deliv Rev, 2009, 61(7/8): 527 [15]Yao Yi, He Yu, Guan Qian, et al. A tetracycline expression system in combination with Sox9 for cartilage tissue engineering[J]. Biomaterials, 2014, 35(6): 1898 [16]黄洪超,苗军,刘春蓉,等.可体内、外示踪的BMP2真核表达载体的构建和表达[J].中华骨科杂志,2010,30(12):1228